| ¿µ¹® | hypophysis, pituitary | ÇÑ±Û | ³úÇϼöü |
|---|---|---|---|
| ¼³¸í | ³ú¹Ù´ÚºÎ¿¡ ÀÖÀ¸¸ç Å;îŰ¾ÈÀå¿¡ À§Ä¡ÇÏ´Â ÀÌÁß±â¿øÀÇ »óÇǼº ¼Òü. Áß¿äÇÑ ³»ºÐºñ Àå±â Áß ÇϳªÀÌ´Ù. Àü¿±, Áß¿±, ÈÄ¿±ÀÇ ¼¼ ºÎºÐÀ¸·Î ÀÌ·ç¾îÁ® ÀÖ°í, ´Ù¸¥ ³»ºÐºñ¼±ÀÇ È°µ¿À» Áö¹èÇϴ ȣ¸£¸óÀ» ºÐºñÇϸç, »ý½Ä°ú ¹ßÀ°¿¡ ¹ÐÁ¢ÇÑ °ü°è°¡ ÀÖ´Ù. |
||
| ¿µ¹® | irradiation | ÇÑ±Û | ¹æ»ç¼±Á¶»ç |
|---|---|---|---|
| ¼³¸í | Áø´ÜÀ̳ª Ä¡·áÀÇ ¸ñÀûÀ¸·Î ¹°Áú¿¡ ¹æ»ç¼±À» ÀÛ¿ë½ÃŰ´Â °ÍÀ» ¸»ÇÑ´Ù. |
||
| HBI | Hemi-Body Irradiation |
|---|---|
| PCI | Prophylatic Cranial Irradiation |
| TBI | Total Body Irradiation |
| ECI | electrocerebral inactivity; eosinophilic cytoplasmic inclusions; extracorporeal irradiation |
| ECIB | extracorporeal irradiation of blood |
| CRT | Cranial irradiation |
|---|---|
| CSI | Craniospinal irradiation |
| EBI | External Beam Irradiation |
| EBRT | External beam irradiation |
| FTBI | Fractionated total body irradiation |
| whole-body irradiation | Irradiation of the whole body with ionizing or non-ionizing radiation. It is applicable to humans or animals but not to microorganisms. (12 Dec 1998) |
|---|---|
| cranial irradiation | The exposure of the head to roentgen rays or other forms of radioactivity for therapeutic or preventive purposes. (12 Dec 1998) |
| hemibody irradiation | Irradiation of one half or both halves of the body in the treatment of disseminated cancer or widespread metastases. It is used to treat diffuse metastases in one session as opposed to multiple fields over an extended period. The more frequent treatment modalities are upper hemibody irradiation (uhbi) or lower hemibody irradiation (lhbi). Less common is mid-body irradiation (mbi). In the treatment of both halves of the body sequentially, hemibody irradiation permits radiotherapy of the whole body with larger doses of radiation than could be accomplished with whole-body irradiation. It is sometimes called "systemic" hemibody irradiation with reference to its use in widespread cancer or metastases. (p. Rubin et al. Cancer, vol 55, p2210, 1985) (12 Dec 1998) |
| prophylactic cranial irradiation | Radiation therapy to the head to prevent cancer from spreading to the brain. (12 Dec 1998) |
| irradiation | Treatment by ionising radiation, such as X-rays or radioactive sources such as radioactive iodine seeds. See: radiation therapy. (16 Dec 1997) |
| total body irradiation | Radiotherapy often given in several doses prior to bone marrow transplantation with the aim of killing any residual leukaemia in the patient. It is used in conjunction with high-dose anti-cancer drugs. The procedure and its side-effects will be discussed individually with the patient. (13 Nov 1997) |
| lymphatic irradiation | External or interstitial irradiation to treat lymphomas (e.g., hodgkin's and non-hodgkin's lymphomas) and lymph node metastases and also some autoimmune diseases, such as rheumatoid arthritis. (12 Dec 1998) |
| anterior pituitary gonadotropin | Any gonadotropin of hypophysial origin; formerly used to designate a single hormone, because it was thought that the anterior hypophysis secreted only one gonadotropin. Synonym: pituitary gonadotropic hormone. (05 Mar 2000) |
| anterior pituitary-like hormone | A glycoprotein with a carbohydrate fraction composed of d-galactose and hexosamine, extracted from the urine of pregnant women and produced by the placental trophoblastic cells; its most important role appears to be stimulation, during the first trimester, of ovarian secretion of the oestrogen and progesterone required for the integrity of conceptus; it appears to play no significant role in the last two trimesters of pregnancy, as the oestrogen and progesterone are then formed by the placenta. Synonym: anterior pituitary-like hormone, choriogonadotropin, chorionic gonadotropic hormone, chorionic gonadotrophic hormone, placenta gonadotropin, placentagonadotropin. (05 Mar 2000) |
| receptors, pituitary hormone | Cell surface proteins that bind pituitary hormones with high affinity and trigger intracellular changes influencing the behaviour of cells. Since many pituitary hormones are also released by neurons as neurotransmitters, these receptors are also found in the nervous system. (12 Dec 1998) |
| receptors, pituitary hormone-regulating hormone | Cell surface receptors that bind the hypothalamic hormones regulating pituitary cell differentiation, proliferation, and hormone synthesis and release, including the pituitary-releasing and release-inhibiting hormones. The pituitary hormone-regulating hormones are also released by cells other than hypothalamic neurons, and their receptors also occur on non-pituitary cells, especially brain neurons, where their role is less well understood. Receptors for dopamine, which is a prolactin release-inhibiting hormone as well as a common neurotransmitter, are not included here. (12 Dec 1998) |
| pharyngeal pituitary | The embryonic remnant of the oral end of Rathke's pouch that is cut off from the adenohypophysis by the developing sphenoid bone; composed chiefly of chromophobes and, under normal conditions, considered physiologically inactive. See: hypophysis. (05 Mar 2000) |
| pituitary | <anatomy, endocrinology> An endocrine gland located at the base of the brain, in the small recess of a bone - certain sections of the pituitary each secretes important hormones including growth hormone (GH) and antidiuretic hormone (ADH). (16 Dec 1997) |
| pituitary adamantinoma | <oncology, tumour> A form of primary brain tumour which develops in the pituitary gland. These tumours often secrete increased quantities of pituitary hormones (for example growth hormone) which can result in conditions such as gigantism and acromegaly. They are often benign and rare and comprise less than 5% of childhood brain tumours. Other symptoms include vision changes, headache and weight gain. Treatment often includes a combination of surgery and radiation therapy. (27 Sep 1997) |
| pituitary adenoma | <radiology> Benign, slow-growing, arises from adenohypophysis (anterior lobe), 5-18% of all intracranial neoplasms plain film (unreliable): enlargement of sella and sloping of the sella floor, erosion of the anterior and posterior clinoid, erosion of the dorsum sellae, calcified in less than10%, may present as a mass in the nasopharynx functioning microadenoma, less than10 mm, 20-30% of pituitary adenomas, types: prolactinoma, corticotrophic adenoma, somatotrophic adenoma, nonfunctioning macroadenoma, more than 10 mm, 70-80% of pituitary adenomas (12 Dec 1998) |
Synonyms : Pituitary Gland Irradiation, Gland Irradiation, Pituitary, Gland Irradiations, Pituitary, Irradiation, Pituitary, Irradiation, Pituitary Gland, Irradiations, Pituitary, Irradiations, Pituitary Gland, Pituitary Gland Irradiations, Pituitary Irradiations
Á¦Ç°¸í |
ÆÇ¸Å»ç |
º¸ÇèÄÚµå | ¼ººÐ/ÇÔ·® | ±¸ºÐ/º¸Çè±Þ¿© |
|---|
Á¦Ç°¸í |
ÆÇ¸Å»ç |
º¸ÇèÄÚµå | ¼ººÐ/ÇÔ·® | ±¸ºÐ/º¸Çè±Þ¿© |
|---|